Schedule 13G ownership disclosure
Rocket Pharmaceuticals Inc
Security class unavailable · CUSIP: 77313F106
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,447,565
- Percent of class
- 6.0400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-021855
- Form type
- SC 13G
- Filer
- ROCKET PHARMACEUTICALS, INC.
- CIK
- CIK 1281895
- Filed
- Feb 13, 2024
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership